U.S. President Donald Trump expressed confidence on Wednesday that China will soon impose the death penalty for fentanyl manufacturing and trafficking, signaling renewed optimism for a bilateral crackdown on the opioid crisis. Speaking ahead of signing the HALT Fentanyl Act, Trump emphasized collaboration with Beijing to halt the flow of synthetic opioids, which have claimed over 450,000 American lives in the past decade.
Fentanyl, a powerful synthetic opioid, remains a top cause of overdose deaths in the U.S., and Washington continues to pressure Beijing to tighten control over precursor chemicals exported from China. Trump’s remarks follow a series of recent moves aimed at reining in the deadly drug trade, including the February imposition of 20% tariffs on Chinese goods linked to fentanyl-related issues.
“I think China’s going to go from doing nothing to issuing the death penalty for those producing fentanyl and sending it here,” Trump told reporters. He added that talks with Chinese leader Xi Jinping were progressing and that Beijing was taking “big steps” in response.
In recent weeks, China has added two more fentanyl precursors—4-piperidone and 1-boc-4-piperidone—to its list of controlled substances. Authorities have also ramped up enforcement, seizing over 2 tons of drugs and arresting 262 individuals for trafficking. Over 1,300 prosecutions and 700 arrests for drug-related money laundering have been reported this year, showing a 2.1% increase from last year.
China, however, has pushed back on U.S. demands to publicize its efforts prominently and has accused Washington of politicizing the fentanyl issue. Still, Trump’s latest remarks suggest a possible breakthrough in cooperation as both nations grapple with rising overdose deaths and escalating tensions.


Global Leaders Condemn Deadly Antisemitic Shooting at Sydney’s Bondi Beach During Hanukkah
Australia Pushes Forward on AUKUS Submarine Program Amid Workforce and Production Challenges
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Senate Set for Vote on GOP Healthcare Plan as Debate Over ACA Subsidies Intensifies
Trump’s Approval of AI Chip Sales to China Triggers Bipartisan National Security Concerns
Ukraine’s NATO Concession Unlikely to Shift Peace Talks, Experts Say
Bolivia Orders Pre-Trial Detention of Former President Luis Arce Over Embezzlement Probe
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions
U.S. Intelligence Briefly Curtailed Information Sharing With Israel Amid Gaza War Concerns
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Trump Criticizes EU’s €120 Million Fine on Elon Musk’s X Platform
Trump Signs Executive Order to Establish National AI Regulation Standard
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Southwest Airlines Has $11 Million Fine Waived as USDOT Cites Operational Improvements
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
U.S. Special Forces Intercept Ship Carrying Military Components Bound for Iran 



